Close Menu
    GCC TabloidGCC Tabloid
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Japan new car sales rise 1.8% in first half of 2026

      July 2, 2026

      Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

      May 18, 2026

      Mercedes-Benz unveils electric C-Class in Seoul

      April 21, 2026

      2027 Mercedes-Benz S-Class adds DIGITAL LIGHT micro-LEDs

      January 30, 2026
    • Business

      Chip boom lifts South Korea into $1 trillion export club

      November 21, 2026

      Botswana reviews proposed 33% power tariff hike today

      November 19, 2026

      Petrol price jump lifts South Africa inflation as SARB weighs rates

      November 18, 2026

      ASEAN signs digital economy pact eyeing $2 trillion by 2030

      November 18, 2026

      AfDB backs Morocco reforms and climate resilience with €434.4m

      November 14, 2026
    • Entertainment

      Sony confirms God of War trilogy remake and PS5 prequel

      February 13, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Moscow hosts historic 47th international festival

      April 19, 2025

      Legal action against ‘Ketamine Queen,’ doctors in Perry overdose

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024
    • Health

      Ebola adds 60 cases in a day as Congo deaths hit 5,568

      November 18, 2026

      Ebola cases top 11,200 as Africa CDC warns of record outbreak

      November 16, 2026

      Yellow fever kills 18 across nine African nations, WHO says

      November 7, 2026

      Dengue kills 173 in October as Bangladesh toll climbs to 418

      November 2, 2026

      Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

      November 2, 2026
    • Lifestyle

      Adidas unveils Treadflow, a treadmill shoe innovation

      August 24, 2025

      U.S. Polo Assn.’s fall-winter 2024 line inspired by Salt Lake City

      September 20, 2024

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023
    • Luxury

      Global luxury market contracts for first time since Great Recession

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      PM Modi meets Prince and Princess of Wales for climate talks

      November 19, 2026

      Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

      November 17, 2026

      Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

      November 16, 2026

      Sheikh Mohamed receives Arab League chief Nabil Fahmy

      November 14, 2026

      Three nations launch carbon crediting initiative at COP31

      November 13, 2026
    • Sports

      Africa hosts first Olympic event as Dakar 2026 YOG begins

      October 30, 2026

      Messi ends Argentina career with 207 caps and 125 goals

      September 1, 2026

      FIA President meets with Hungarian PM and Czech President

      July 28, 2026

      Portugal fall to Spain as Ronaldo legacy closes

      July 7, 2026

      Brazil exits World Cup after Norway Round of 16 victory

      July 6, 2026
    • Technology

      MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

      November 3, 2026

      Sam Altman calls UAE most forward-looking country on AI

      November 3, 2026

      Apple iPhone Duo sets a new benchmark for foldable design

      November 2, 2026

      Apple brings Touch and PROLED XDR display to MacBook Pro

      October 29, 2026

      Integrated Identity Enters Global Top 0.1% with Rare 100/100 Google PageSpeed

      October 29, 2026
    • Travel

      Air Arabia Egypt launches Cairo to Al Ain flights soon

      November 20, 2026

      Dubai Airports expects over 70 million guests in 2026

      November 18, 2026

      Over 9 million visitors lift Tunisia tourism income 3.4%

      November 17, 2026

      Damascus becomes Air Arabia Dammam’s second foreign route

      November 17, 2026

      Türkiye aims to rank sixth in global tourism revenue

      October 21, 2026
    GCC TabloidGCC Tabloid
    Home » China’s Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange
    PR Newswire

    China’s Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

    June 5, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SHANGHAI, June 5, 2026 /PRNewswire/ — LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, listed on the Hong Kong Stock Exchange on June 5, 2026 Beijing time, marking the seventh IPO for Qiming Venture Partners this year. LongBio Pharma (01779.HK) issued its shares at a price of HK$96.06 per share and opened at HK$144.30 per share with a market capitalization of HK$10.7 billion.

    Qiming Venture Partners invested in the B2 round of financing of LongBio Pharma as the lead-investor in 2024 and invested in the C round as the co-lead-investor in 2025. Before the IPO, Qiming Venture Partners held a 4.27 percent stake in LongBio Pharma as one of its major institutional investors.

    Founded in 2020, LongBio Pharma focuses on in-house discovery and development of biopharmaceuticals targeting on allergic and autoimmune diseases. Its founding team has rich experience in its field and has achieved outstanding results in discovery of drugs, clinical development, and registration procedures. Dr. Sun Naichao, co-founder of LongBio Pharma, is the key original inventor of omalizumab, the world’s first pioneering anti-IgE antibody. He has been devoting himself to the allergic diseases for decades and is a pioneering scientist in development of drugs for allergic diseases. Dr. Liu Heng, co-founder, Chairman and CEO of the firm, has over 15 years of experience in research and development and commercialization of biopharmaceutical drugs and has played a pivotal role in both domestic and international programs of development of several innovative drugs.

    LongBio Pharma has developed a comprehensive product pipeline for biologic treatments targeting rhinology, dermatology, respiratory, hematology, nephrology and other autoimmune diseases. The firm’s core product LP-003 is a novel anti-IgE antibody. Its main function is to block free IgE in the blood and tissues and thus inhibit the occurrence of IgE-mediated allergic reactions. According to the top-line results, LP-003 exhibited significantly better efficacy than omalizumab in the treatment of chronic spontaneous urticaria (CSU). LP-005, a major product of LongBio Pharma, is a novel bi-functional complement antibody-fusion protein targeting both C5 and C3b, has leading potential globally, and shows therapeutic potential compared with single-target complement inhibitors. 

    “In 2024, omalizumab was approved in the United States, opening up commercialization opportunities. The prevalence of allergic diseases such as allergic rhinitis, asthma, and chronic urticaria has been rising in China. Based on clinical needs, technical barriers, team strength, and market inflection points, Qiming Venture Partners chose to invest in LongBio Pharma. The listing of LongBio Pharma is a key milestone for the company’s transition from the laboratory to commercialization, and the firm is expected to grow into a leading enterprise in the field of allergic diseases in China. LongBio Pharma is also an original innovation investment made by Qiming Venture Partners during the medical capital winter, which confirms Qiming Venture Partners’ resilience in navigating through industry cycles and its independent judgment ability for projects. Qiming Venture Partners will continue to focus on addressing unmet clinical needs and always pursue investments in cutting-edge medical innovation with global competitiveness,” Dr. Kan Chen, a partner of Qiming Venture Partners and the co-lead of the Qiming’s investments in the healthcare sector, said.

    About Qiming Venture Partners

    Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

    Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.

    Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.ai, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

    Cision View original content:https://www.prnewswire.co.uk/news-releases/chinas-leading-innovative-drug-developer-for-allergic-and-autoimmune-diseases-longbio-pharma-lists-on-hong-kong-stock-exchange-302792533.html

    Related Posts

    ADFW 2026 Unveils Largest-Ever Partner-Driven Programme, Headlined by L’IMAD

    November 20, 2026

    Morrison Announces Middle East Expansion with New Office in Abu Dhabi’s ADGM

    November 20, 2026

    TÜV SÜD opens its International Technology & Innovation Campus in the Guangdong-Hong Kong-Macao Greater Bay Area

    November 20, 2026

    ROTOBOOST Secures Strategic Investment from Aramco Ventures to Accelerate Global Deployment of Methane Pyrolysis Technology for Low-Carbon Hydrogen and Advanced Carbon Materials

    November 20, 2026

    Huawei Unveils Financial AI Scaling Capabilities at Singapore FinTech Festival 2026

    November 20, 2026

    UnionPay International and Transsion Announce Global Partnership to Bring UnionPay Payments to T Wallet, Debuting in Pakistan

    November 19, 2026
    Latest News

    Chip boom lifts South Korea into $1 trillion export club

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    November 20, 2026

    Botswana reviews proposed 33% power tariff hike today

    November 19, 2026
    © 2026 GCC Tabloid | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.